Health tech takes aim at Alzheimer’s and home care startups to watch

You’re examining the world-wide-web edition of STAT Health Tech, our guideline to how tech is reworking the everyday living sciences. Sign up to get this newsletter delivered in your inbox every single Tuesday and Thursday. 

Tech companies go immediately after Alzheimer’s

The uncertain potential of Aduhelm has left an opening for program and unit organizations who want to deal with Alzheimer’s condition. Whilst pharma providers keep on to battle with the root lead to of the disease, health care technological innovation organizations can simply just address the symptoms, like agitation, depression, and cognitive decline. Of training course, irrespective of a flurry of expense in organizations like MedRhythmsCognito, and other folks hoping to take care of the sickness, none have verified that they can enhance any meaningful evaluate for dementia clients. Katie has the complete story.

advertisement

5 home health tech trends to view

Tech startups and health care incumbents alike are poised to income in on what analysts say is an unstoppable shift from offering treatment in the clinic to aging patients’ properties. Medicare’s predicted to deal with 80 million beneficiaries by 2030, and organizations are scrambling to build out the fundamental infrastructure for home health care, ranging from strong professional medical products shipping to passive important indication monitoring to acute treatment at the patients’ bedside. Mohana has a nearer look at the home health tech trends drawing expense, including companies creating the tech infrastructure to supply acute treatment at home.

advertisement

Trading nasal swabs for smart toilets

Public health experts are hunting for fewer invasive, passive approaches to maintain tabs on Covid, like wastewater monitoring. Researchers from Stanford suggest smart bogs with automatic sample assortment and diagnostics crafted-in could aid make that a sustainable extensive-expression remedy. This sort of “COV-ID” bogs could be mounted in remarkably-trafficked general public spots like malls or campuses.  When a person sits down to do their enterprise, they can use their telephone to scan a QR code and consent to screening. Individuals could rapidly get final results, and public health experts could use the facts to augment surveillance of the virus. Even if such a program could be created, it would involve privateness safeguards, and there is no assure that sufficient people would take part. The scientists propose this kind of a platform could be useful past the pandemic as “a strong infrastructure for checking upcoming novel illness.” (Sheesh. Way too soon!)

Health tech companies raise $100M+ 

  • Brightline, which offers behavioral health services for younger folks, raised $105 million in a Series C spherical valuing the corporation at $705 million. The round was led by KKR with participation from GVOptum VenturesOak HC/FT, and others.
  • ConcertAI raised a $150 million Series C round from Sixth Road at a valuation of $1.9 billion.
  • VivoSense, a startup developing digital biomarkers lifted a $25 million Sequence A led by Perceptive Xontogeny Venture Fund and Debiopharm Innovation Fund.
  • Jeenie, a digital interpretation platform, raised a $9.3 million Series A led by Transformation Cash.
  • Hims & Hers declared a offer with principal treatment provider Carbon Health to aid heat handoffs when individuals need care for more complex ailments.
  • Diagnostics and digital care provider LetsGetChecked acquired genetic tests provider Veritas Genetics for an undisclosed total?
  • Valar Labs, an AI most cancers startup, elevated a $4 million seed spherical led by Andreessen Horowitz.

Staff file

  • SteadyMD named Google VP of company functions & approach and business enterprise finance officer Kristen Gil to its board of advisors.
  • Miruna Sasu is now the president and CEO of COTA, a authentic-earth oncology facts enterprise. Previously she labored as head of scientific demo feasibility and knowledge science at Johnson & Johnson and as head of innovation and digital health at Bristol-Myers Squibb.

What we’re looking through